These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 26493317)
41. SPACER: Server for predicting allosteric communication and effects of regulation. Goncearenco A; Mitternacht S; Yong T; Eisenhaber B; Eisenhaber F; Berezovsky IN Nucleic Acids Res; 2013 Jul; 41(Web Server issue):W266-72. PubMed ID: 23737445 [TBL] [Abstract][Full Text] [Related]
42. Prediction of Protein Allosteric Signalling Pathways and Functional Residues Through Paths of Optimised Propensity. Wu N; Yaliraki SN; Barahona M J Mol Biol; 2022 Sep; 434(17):167749. PubMed ID: 35841931 [TBL] [Abstract][Full Text] [Related]
43. Allosteric Modulators of Protein-Protein Interactions (PPIs). Ni D; Liu N; Sheng C Adv Exp Med Biol; 2019; 1163():313-334. PubMed ID: 31707709 [TBL] [Abstract][Full Text] [Related]
44. Identifying Allosteric Binding Sites in Proteins with a Two-State Go̅ Model for Novel Allosteric Effector Discovery. Qi Y; Wang Q; Tang B; Lai L J Chem Theory Comput; 2012 Aug; 8(8):2962-71. PubMed ID: 26592133 [TBL] [Abstract][Full Text] [Related]
45. AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses. Huang M; Song K; Liu X; Lu S; Shen Q; Wang R; Gao J; Hong Y; Li Q; Ni D; Xu J; Chen G; Zhang J Nucleic Acids Res; 2018 Jul; 46(W1):W451-W458. PubMed ID: 29757429 [TBL] [Abstract][Full Text] [Related]
46. Advances in the allostery of angiotensin II type 1 receptor. Zhang X; Zhang S; Wang M; Chen H; Liu H Cell Biosci; 2023 Jun; 13(1):110. PubMed ID: 37330563 [TBL] [Abstract][Full Text] [Related]
47. Are the Apo Proteins Suitable for the Rational Discovery of Allosteric Drugs? An X; Lu S; Song K; Shen Q; Huang M; Yao X; Liu H; Zhang J J Chem Inf Model; 2019 Jan; 59(1):597-604. PubMed ID: 30525607 [TBL] [Abstract][Full Text] [Related]
48. Is allostery an intrinsic property of all dynamic proteins? Gunasekaran K; Ma B; Nussinov R Proteins; 2004 Nov; 57(3):433-43. PubMed ID: 15382234 [TBL] [Abstract][Full Text] [Related]
49. Progress in Allosteric Database. Song K; Zhang J; Lu S Adv Exp Med Biol; 2019; 1163():65-87. PubMed ID: 31707700 [TBL] [Abstract][Full Text] [Related]
50. Computational elucidation of allosteric communication in proteins for allosteric drug design. Ni D; Liu Y; Kong R; Yu Z; Lu S; Zhang J Drug Discov Today; 2022 Aug; 27(8):2226-2234. PubMed ID: 35314339 [TBL] [Abstract][Full Text] [Related]
54. Combining Allosteric and Orthosteric Drugs to Overcome Drug Resistance. Ni D; Li Y; Qiu Y; Pu J; Lu S; Zhang J Trends Pharmacol Sci; 2020 May; 41(5):336-348. PubMed ID: 32171554 [TBL] [Abstract][Full Text] [Related]
55. PockDrug-Server: a new web server for predicting pocket druggability on holo and apo proteins. Hussein HA; Borrel A; Geneix C; Petitjean M; Regad L; Camproux AC Nucleic Acids Res; 2015 Jul; 43(W1):W436-42. PubMed ID: 25956651 [TBL] [Abstract][Full Text] [Related]
56. Characteristics of Allosteric Proteins, Sites, and Modulators. He X; Ni D; Lu S; Zhang J Adv Exp Med Biol; 2019; 1163():107-139. PubMed ID: 31707702 [TBL] [Abstract][Full Text] [Related]
57. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs. Bartuzi D; Kaczor AA; Matosiuk D Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568 [TBL] [Abstract][Full Text] [Related]
59. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target. Janero DR; Thakur GA Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124 [TBL] [Abstract][Full Text] [Related]
60. Allosteric sites can be identified based on the residue-residue interaction energy difference. Ma X; Qi Y; Lai L Proteins; 2015 Aug; 83(8):1375-84. PubMed ID: 25185787 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]